Actively Recruiting

Age: 18Years - 45Years
FEMALE
Healthy Volunteers
NCT02297724

MRI Assessment of Placental Health

Led by Boston Children's Hospital · Updated on 2025-12-12

80

Participants Needed

2

Research Sites

752 weeks

Total Duration

On this page

Sponsors

B

Boston Children's Hospital

Lead Sponsor

M

Massachusetts General Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The ultimate goal of this project is to develop methods that allow informed decision-making on the delivery time of fetuses that are at increased risk of stillbirth due to IUGR. In placenta related IUGR pregnancies, there can be multiple concurrent placental pathologies. Although there is no specific correspondence between a single type of pathology and IUGR, the common result of these pathologies is placental insufficiency, which limits the maternal-fetal exchange. Oxygen and nutrition transport is known to be hindered in IUGR placentas due to obstructed or abrupt vasculature, massive fibrin deposition, and inflammation in the villous and intervillous space (villitis). Thus one potential approach to distinguish IUGR pregnancies from normal ones is to assess the efficiency of placental transport. Based on the hypothesis that efficiency of oxygen transport is representative for overall oxygen and nutrition transport in placenta, the investigators propose to characterize the blood oxygenation and blood perfusion in placenta in vivo via MRI, and use it as an index for better stratification in the IUGR risk group. The investigators will also consider alternative MRI approaches such as structural, diffusion and spectroscopy measurements inside the placenta, which might reflect the state of placental transport and reveal the status of placental health. Specific aims: 1) To correlate the MRI metrics that differentiate placental insufficiency from normal placenta transport with histopathology data of the placenta. 2) To correlate the MRI metrics that reflects placental insufficiency with fetal outcome

CONDITIONS

Official Title

MRI Assessment of Placental Health

Who Can Participate

Age: 18Years - 45Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant mother with twin gestation diagnosed with selective IUGR based on ultrasound, including proven chorionicity and fetal weight discordance of 20% or more or growth restriction below 10th percentile
  • Pregnant mother with singleton gestation diagnosed with IUGR based on ultrasound, including growth restriction below 10th percentile and Doppler signs of placental insufficiency or low amniotic fluid
  • Gestational age greater than 18 weeks
  • Pregnant mother aged 18 to 45 years, clinically stable and able to safely tolerate fetal MRI study
Not Eligible

You will not qualify if you...

  • Fetuses or infants with chromosomal anomalies or known genetic disorders
  • Fetuses or infants with major congenital malformations
  • Any condition that compromises safety or data quality as judged by the investigator
  • Mothers with contraindications to MRI such as pacemaker, metal implants, or large body size
  • Mothers with claustrophobia
  • Mothers medically unstable for MRI study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

2

Hospital Universitario de Fuenlabrada

Madrid, Spain, 28942

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here